Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Eastwood
Bio-Medical
Canada Inc.
(EBM) July 4, 2018
2018年7月4日
1130-4871 Shell Road, Richmond, BC, Canada V6X 3Z6 1
This presentation contains forward-looking statements and forward-looking information within the meaning of applicable
securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may",
"will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking
information or statements. The forward-looking statements and information are based on certain key expectations and
assumptions made by the Eastwood Bio-Medical Canada Inc. (the Company) and the Company’s affiliates, including
expectations and assumptions concerning TSX Venture Exchange approvals. Although the Company believes that the
expectations and assumptions on which such forward-looking statements and information are based are reasonable,
undue reliance should not be placed on the forward-looking statements and information because the Company can give no
assurance that they will prove to be correct.
Forward-Looking Statement / 前瞻性陳述
2
Eastwood Bio-Medical Canada Inc. is located at Richmond, British
Columbia, Canada near the Vancouver International Airport.
Eastwood Bio-Medical Canada Inc.位於加拿大卑詩省列治文,臨近溫
哥華國際機場。
3
Canadian History in Diabetes Leadership
加拿大是糖尿病行業的全球先驅
Canada has long been considered the global
pioneer of diabetes industry. In 1922, Frederick
Grant Banting discovered insulin, which is
considered one of the most important
discoveries of the 20th century. The Nobel
Foundation awarded his team Nobel Prize in
Physiology and Medicine in 1923.
人們長期以來一直將加拿大視為糖尿病行 業的全球先驅。1922年,弗雷德裡克·班廷 (Frederick Grant Banting)發現了胰島素,這 被認為是20世紀最重要的發現之一。諾貝 爾基金會於1923年授予弗雷德裡克·班廷的 團隊諾貝爾生理學和醫學獎。
4
Who We Are
關於我們
5
A biomedical research and development company specializing in metabolic
disorders such as diabetes, obesity, hypertension, and Alzheimer‘s disease.
一家生物醫學研發公司,致力於研究糖尿病、肥胖症、高血壓和阿爾 茨海默病等代謝紊亂疾病的解決方案。
We have successfully developed over 70 Eleotin® products including over 50
Health Canada (Canadian FDA) approved products.
我們已經成功開發了70多種Eleotin®產品,其中包括50多種加拿大衛生 部(加拿大FDA)批准的產品。
Advertising Standards Canada (ASC) approved our flagship product, Eleotin®
Bentley to be marketed as ―World‘s #1 Doctor recommended Natural Source
Healthy Blood Glucose Promoting Product available in Canada‖.
加拿大廣告標準委員會(ASC)批准本公司的旗艦產品Eleotin® Bentley用 ―世界第一醫生推薦的純天然加拿大健康血糖促進產品‖名義
進行市場推廣。
ASC
Approval
Number
ASC批准 文號
6
Who We Are
關於我們
7
Over 500,000 users are estimated to have used and benefited from
Eleotin® .
估計有超過500,000名使用者用過Eleotin®並從中受益。
More than four international diabetes associations strongly recommend
(endorsed) Eleotin® .
超過四個國際糖尿病協會強烈推薦(認可)Eleotin®。
Eleotin® was the recipient of 2010 Best Metabolism Disorder
Treatment of the Year Award and
Eleotin®獲得2010年度最佳新陳代謝紊亂治療獎和
7th Annual International Brand Packing Awards
第七屆年度國際品牌包裝獎
EBM: The Recent Focus of Financial Analysts and
Investors EBM:金融分析師和投資者近期所關注的焦點
Company production capacity ‗recently‘ has
increased to:
公司產能―最近‖實現增長:
▰ Up to 3 million capsules can be
produced and 10,000 bottles can be
packaged per day.
每天可生產多達300萬粒膠囊,每 天可包裝10,000瓶膠囊。
▰ A half million dollar worth of products
in retail value can be produced daily.
每天可生產零售價值達$50萬的產 品。
▰ Up to $7 million in possible savings in annual manufacturing costs.
所節約的年度製造成本高達$700萬。 8
EBM: The Recent Focus of Financial Analysts and
Investors EBM:金融分析師和投資者近期所關注的焦點
9
EBM: The Recent Focus of Financial Analysts and
Investors EBM:金融分析師和投資者近期所關注的焦點
New Product Approvals and Licenses (45 NPN Numbers).
新產品批號和許可證(45 NPN批號)。
10
June 29 2018, Eastwood Bio-Medical Canada Enters Binding Terms for Asian
Exports
2018年6月29日,Eastwood Bio-medical Canada Inc.簽訂產品出口亞洲協議
11
▰ On June 29 2018, EBMC announced to enter binding terms for
Asian exports. Accordingly, 900% increase in revenue was
announced.
2018年6月29日,EBMC宣佈與一家亞洲分銷公司就採購訂單 達成具有約束力的條款。因此,EBMC宣佈收入增加900%。
▰ New manufacturing capabilities allow us to finally start producing
highly advanced and complex products with the best quality and
process control on a meaningfully larger scale.
新的製造能力令我們能夠大幅提高產能,採用最佳的工藝控 制技術,開始生產非常先進、複雜的高品質產品。
▰ EBMC is no longer being bound by production limitations.
EBMC不再受產量限制的約束。
Stock Prices in the Past 6 Months
過去6個月股價
The market has begun paying attention.
市場開始關注本公司。
12
Trading Volume in the Past 6 Months
過去六個月成交量
15 Jan 29 Jan 12 Feb 26 Feb 12 Mar 26 Mar 9 Apr 23 Apr 7 May 21 May 4 Jun 18 Jun 2 Jul
601 K
13
Market Potential: Prevalence of Diabetes By IDF Region
市場潛力:國際糖尿病聯盟地區的糖尿病患病率
14 Global Report on Diabetes – WHO 2016
全球糖尿病報告——世衛組織2016年
Market Potential: Prevalence of Alzheimer‘s and Dementia
市場潛力:阿爾茨海默氏症和癡呆症的患病率
15
全球的阿爾茨海默氏症和癡呆症患者
Market Potential: Prevalence of Hypertension
市場潛力:高血壓病的患病率
16
Global Prevalence of Hypertension
over 1.3 Billion
全球有超過13億高血壓病患者
Market Values of Diabetes, Hypertension and Alzheimer‘s
糖尿病、高血壓和阿爾茨海默氏症的市場規模
17
▰ Type 2 diabetes market to more than double, to $64 billion by 2026
治療2型糖尿病的市場規模將增加一倍以上,到2026年達到 $640億
▰ Global hypertension market will reach USD $32 billion by the end of
2020
到2020年底,全球治療高血壓病的市場規模將達到320億美元。
▰ The global Alzheimer's market is expected to $10.4 billion in 2021
預計到2021年,全球治療阿爾茨海默氏症的市場規模將達 $104億
Our Claim: The Only Option
我們的主張:我們的產品是患者的唯一選擇
18
We believe that our products are the ‗only‘ option for
those inflicted with these diseases.
我們相信,我們的產品是患有這些疾病的患者的 “唯一”選擇。
We also believe we will remain the only option in the
near future.
我們也相信,在不久的將來,我們的產品仍將是 患者的唯一選擇。
Here is why...
理由是…
Pharmaceuti
cal Drugs and
Insulin
Other Herbal
Products
Traditional
Chinese Medicine
Folkloric
Treatmen
ts/
Alternative
Treatments
Eleotin®
Known - Can be
used with other
pharmaceutical
drugs
Unknown
Unknown
Unknown
Known - Can be
safely used with
other
pharmaceutical
drugs
19
Advantage #1: Modes of Action Known
● The Modes of Actions for most non-pharmaceutical treatments are unproven. They can
not be used with pharmaceutical drugs out of fear of unknown adverse interactions.
● Eleotin® 's modes of actions are known and proven. Eleotin® is safe when used with
oral pharmaceutical drugs and insulin.
● In fact, Eleotin® reduces the side effects and resistance of oral pharmaceutical drugs
and insulin. When used with Eleotin®, oral pharmaceutical drugs and insulin become
safer more efficacious and less habit forming.
藥物和胰島素
其他草藥
中藥
民間療法/非傳統療法
Eleotin®
已知——可與其 他藥物一起
使 用
未知
未知
未知
已知——可安全 地與其他藥物 一起使用
20
優勢1:作用機制已知
● 大多數非藥物療法的作用機制尚未得到證實。 由於擔心未知的不良相互作 用,非藥物療法不能與藥物一起使用。
● Eleotin®的作用機制眾所周知。 當Eleotin®與口服藥物和胰島素一起使用時, Eleotin®安全有效。
● 事實上,Eleotin®能減少口服藥物和胰島素的副作用和抗藥性。當口服藥物 和胰島素與Eleotin®一起使用時,能實現安全有效的療效並減少藥物依賴。
21
Pharmaceuti
cal Drugs and
Insulin
藥物和胰島素
Other Herbal
Products
其他草藥
Traditio
nal
Chinese
Medicine
中藥
Folkloric Treatments/
Alternative
Treatments
民間療法/非傳統療法
Eleotin®
None
無
None
無
Unknown
未知
None
無
Semi-
permanent efficacy
半永久性的長期改善
Advantage #2: Long Term Effects
優勢2:長期影響
● With proven insulin resistance reduction, Eleotin® provides semi-permanent long
term improvement while other treatments do not give such long term benefits.
隨著胰島素抗病力的降低,Eleotin®可提供半永久性的長期疾病改善,而其他治療方法則 無法帶來長期效益。
● Most other treatments only have short term control benefits, and must be used permanently.
大多數其他療法只有在短期內控制疾病,必須永久使用這些療法。
● But a person can stop Eleotin® with no harmful side effects after the body has a attained structural
change. 但使用Eleotin®的患者在身體實現結構變化後,可以停止使用Eleotin®並且沒有任
何有害副作用。
Pharmaceuti
cal Drugs and
Insulin
藥物和胰島素
Other Herbal
Products
其他草藥
Traditional
Chinese Medicine
中藥
Folkloric
Treatmen
ts/
Alternative
Treatments
民間療法/非傳
統療法
Eleotin®
No
否
No
否
No
否
No
否
Yes
是
22
Advantage #3: Preventive Effects
優勢3:預防效果
● A person who does not have diabetes can use Eleotin® for general health and
preventive purposes. Other treatments do not offer such safe options.
非糖尿病患者可以用Eleotin®改善健康狀況和進行糖尿病預防。其他療法無 法提供這一安全選項。
Pharmaceutical
Drugs and Insulin
藥物和胰島素
Other Herbal
Products
其他草藥
Traditional
Chinese Medicine
中藥
Folkloric Treatments/
Alternative
Treatments
民間療法/非傳統療法
Eleotin®
Short term and
invasive treatment.
Toxic and severe
side effects.
Resistance
develops. Ever
increasing dosages.
短期和侵入性治療、 有毒和嚴重的副作 用、產生抗藥性、 需要不斷提高劑量。
Shotgun
approach. Most of
them rely on
artificial
indigestion to
lower the blood
sugar
突擊式營銷。大 多依靠人為製造 消化不良來降低
血糖
Shotgun approach.
Most of them rely
on artificial
indigestion to
lower the blood
sugar
突擊式營銷。大 多依靠人為製造 消化不良來降低
血糖
Shotgun approach.
Most of them rely on
artificial indigestion
to lower the blood
sugar
突擊式營銷。大多 依靠人為製造消化 不良來降低血糖
Long term and
safe beneficial
effects. General
health
improvements.
長期安全的療效, 改善總體健康狀
況
23
Conclusion 結論
● If you compare Eleotin® with other treatments from all perspectives, it‘s natural to
conclude that Eleotin® is the only option.
如果您從所有角度比較Eleotin®與其他療法,就能自然地得出結論:Eleotin®
是唯一的選擇。
ASC approved Eleotin® to be ―World‘s #1 Doctor recommended Natural Source Healthy Blood Glucose
Promoting Product available in Canada‖.
加拿大廣告標準委員會(ASC)批准Eleotin用―加拿大市場上全球首個醫生推薦的天然來源健康血糖 促進產品‖名義進行市場推廣。
● World‘s No.1 Doctor recommended: Over 3000+ doctors / 全球首個醫生推薦:逾3000名醫生推薦
● Over 2,500 Newspaper & Television Acclaims (including New York Times #1 Best Sellers) / 得到超過
2500條報紙和電視臺讚譽(包括《紐約時報》排名第一的暢銷書 )
● Researched/Clinically tested by Universities and Governments / 由大學和政府進行研究/臨床測試
● Strongly recommended by more than 4 International Diabetes Associations / 得到4個以上國際糖尿
病協會的強烈推薦
● Licenses issued by 8 Government Authorities / 獲得8個政府機關簽發的許可證
● Best Metabolism Disorder Treatment of the Year 2010 Award Winner / 獲得2010年度最佳新陳代謝
紊亂治療獎
● More than 500,000 Users as of beginning of this year / 截至今年年初,已有超過500,000名使用者
● Over 2,000 Youtube testimonials / 超過2,000個Youtube視頻推薦
24
As a Result,
因此,
International Diabetes Associations Endorsements of
Eleotin®
國際糖尿病協會認可Eleotin®
25
26
Recommendations of Medical
Professionals
Dr. Chu, Beijing China “Because of Eleotin my
husband doesn’t need any
pharmaceutical drugs. He’s normal now.”
Dr. J. Yoon “This remedy will restore
near normalcy for 70% of
Type II diabetics.”
Dr. M. Kuypers “I am using it myself, with
great benefit. My own
experience have been
most encouraging. I am
looking forward to finally
being able to do
something about insulin
resistance.”
Dr. L. Lipskaya, Bacteriologist
“After I started using Eleotin, I
felt an improvement in my
health conditions. Now I
recommend Eleotin to every
person who are suffering from
Type II diabetes.”
Dr. E. Echano “Everyone should know about
this. i observed excellent
clinical result. This unique
herbal formulations long
lasting effects are truly
amazing.”
Dr. M. Sichel “A pathfinding discovery
in the reversal of
diabetes.”
Dr. D. Walker “Eleotin is effective in
regulating blood glucose
levels.”
Dr. C. L. Broadhurst “Eleotin is blend of many
promising herbs that
dramatically lower blood
sugar.”
Dr. P. Singh Ayurvedic Medicine
“I want to recommend
Eleotin especially to Type II
diabetics. It will help them in
controlling their blood
glucose levels.”
Recommendations of Medical Professionals
醫療專業人員推薦
Chu博士,中國北京 “因為Eleotin,我的丈夫不需
要任何藥物。他現在過著正 常健康的生活。”
J. Yoon博士 “對於70%的2
型糖尿病患者, 這種藥物將使患者恢復到接 近健康正常的狀態。”
M. Kuypers博士 “我自己使用它,它給我帶來
了很大的好處。我自己的經 歷是最令人鼓舞的。我期待 著能夠對胰島素抗藥性做些 什麼。”
L. Lipskaya博士,細菌學家 “在我開始使用Eleotin之後,我感 覺自己的健康狀況有所改善。現在 我向所有患有II型糖尿病的人推
薦 Eleotin。”
E. Echano 博士 “每個人都應該知道這一點。我 觀察到Eleotin有極好的臨床效果。
這種獨特的草藥配方有持久療效, 確實令人驚歎。”
M. Sichel博士 “Eleotin是逆轉糖尿病的突破 性發現。”
D. Walker博士 “Eleotin可有效調節血糖水 平。”
C. L. Broadhurst博士 “Eleotin由許多草藥混合而成, 可以顯著降低血糖。”
P. Singh博士 阿育吠陀醫學 “我想特別向II型糖尿病患者推 薦Eleotin。它將幫助患者控制 血糖水平。”
27
Clinical Studies, Publications, Approvals and Licenses
臨床研究、出版物、批文和許可證
28
Clinical Studies, Publications, Approvals and Licenses
臨床研究、出版物、批文和許可證
29
Clinical Studies, Publications, Approvals and Licenses
臨床研究、出版物、批文和許可證
Comments on Eleotin by
Korean National Diabetes
Association
韓國國家糖尿病協會對 Eleotin的評論
30
Clinical Studies, Publications, Approvals and Licenses
臨床研究、出版物、批文和許可證
Comments on Eleotin by
Korean Pharmaceutical
Manufacturers‘ Association
韓國藥品製造商協會對 Eleotin的評論
31
Africa's Best Diabetic & Hypertension Management Drug in 2010
2010年非洲最佳糖尿病和高血壓管理藥物
32
Testimonials
推薦材料
33
We have over 5,000 video testimonials on Youtube by users and doctors
with all real names and many contact information to verify.
我們在Youtube上有超過5,000個使用者和醫生的推薦視頻,使用者
和醫生提供真實姓名和許多聯繫信息,以驗證真實性。
Established Retail Lines
成熟的產品線
Eleotin® Bentley
● Helps promote healthy glucose levels.
有助於促進達到健康血糖水平。 ● Long-term blood glucose normalization effects.
達到長期實現正常血糖的效果。 ● General health improvement.
提升總體健康狀況。
Eleotin® Ma5
● Powerful anti-oxidation powers that are
preserved superbly.
強大的抗氧化能力,保存完好。 ● High quality Vitamin C group ingredients.
含高品質的維生素C組成份。
34
Established Retail Lines
成熟的產品線
Eleotin® LBM
● for hyperactivity of the liver (high blood pressure). 用於肝過度活躍(高血壓)。
● To cut the vicious cycle between high blood sugar and
high blood pressure caused by prescription drugs.
減少處方藥引起的高血糖和高血壓之間的惡性循環。
Eleotin® Pedo-Protection Socks Eleotin® 保護襪 ● Anti-Fungal & Anti-Bacterial
抗真菌和抗菌 ● Auto Regulating Mesh Top
自動調節頂部網狀設計 ● Treated Inner Toe Seam
腳趾縫舒適 ● Holistic & Gentle Neck Pressure
舒緩腳脖壓力 35
Founder - Dr. Youngsoo Kim
創始人 – 金榮洙博士
● Advises Various Governments and senior management of numerous
Korean firms including Hyundai, Gold Star, and Samsung
為各個政府、包括現代、金星和三星在內的眾多韓國企業的
高級管理人員提供建議
● CEO of Mutsumi Enterprises Canada Corp.
Mutsumi Enterprises Canada Corp.首席執行官
● Vice President of Toshin Butsuryu (Toyota Automobile Group
Japan)
東新物流株式會社(豐田(日本)汽車集團)副總裁
● Protocol secretary in the Korean Presidential Palace
韓國總統府禮賓司秘書
● Assistant Professor of Finance at the University of Alberta in
Edmonton
埃德蒙頓阿爾伯塔大學金融學助理教授
● Massachusetts Institute of Technology (Ph.D. in Economics) 1987
1987年畢業于麻省理工學院(經濟學博士)
36
Board of Directors
董事會成員
Yunji Kim President, CEO and Director 總裁、首席執行官兼董事
● President since April 2013, Director since October 2012 2013年4月起擔任總裁; 2012年10月起擔任董事
● New York State Bar admission 2012 2012年加入紐約州律師協會
● LL.M. in Taxation, Georgetown University Law Center, 2011 2011年獲得了喬治敦大學法 學院法學碩士學位
37
Peter Chen CFO and Director 首席財務官兼董事
● Executive Director of Proterra Management Group Inc. 目前在私營諮詢公司Proterra Management Group Inc.擔任 執行董事。
Dr. Marcus Kuypers Marcus Kuypers博士 Director 董事
● Medical Doctor 醫學博士
● Physician at AB Staffing since November 2011 自2011年11月至今一直是AB Staffing的在職醫生
● Accretive Health from October 2011 to February 2013 2011年10月至2013年2月任職 於Accretive Health
● Doctors Home Visits from September 2001 to August 2011 2001年9月至2011年8月在 Doctors Home Visits供職
● Emergency Medicine physician since November 2011 自2011年11月至今,一直擔 任急救醫生。
Dr. Terrance Owen Terrance Owen博士 Director 董事
● Director of Pacific Paredyme Energy Inc. 目前擔任Pacific Paradyme Energy Inc.董事
● CEO of CellMedX Corp. 擔任CellMedx Corp.首席執行官
● President and CEO of Nuva Pharmaceuticals Inc. until June 2013 2013年6月前曾擔任Nuva Pharmaceuticals Inc.的總裁兼 首席執行官。
Appendix - Financial Information
附錄——財務信息
38
Most updated information available upon request
請在網站上申請獲取公司最新信息
www.eleotin.ca
www.eleotin.cn
Yunji Kim
Unit 1130-4871 Shell Road Richmond, B.C. Canada, V6X 3Z6
604.247.2100 or 1.888.669.4372
www.eleotin.ca
www.eleotin.cn 39